Emergent Stock Story

EBS
 Stock
  

USD 29.72  0.29  0.97%   

Emergent investor sentiment overview provides quick insight into current market opportunities from investing in Emergent Biosolutions. The current market sentiment together Emergent Biosolutions' historical and current headlines can help investors to time the market. Many technical investors use Emergent Biosolutions stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Investing Opportunities.
  
Emergent Biosolutions stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Emergent daily returns and investor perception about the current pice of Emergent Biosolutions as well as its diversification or hedging effects on your existing portfolios.
Payment of 1715 shares by Robert Kramer of Emergent Biosolutions subject to Rule 16b-3
Filed transaction by Emergent Biosolutions Inc director. Payment of exercise price or tax liability by delivering or withholding securities

Emergent insider trading alert for payment of common stock by Robert Kramer, President and CEO, on 23rd of May 2022. This event was filed by Emergent Biosolutions Inc with SEC on 2022-03-02. Statement of changes in beneficial ownership - SEC Form 4. Robert Kramer currently serves as cfo, interim executive vice president - corporate services division, principal financial and accounting officer, treasurer of Emergent Biosolutions

Cash Flow Correlation

Emergent Biosolutions' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Emergent Biosolutions' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Emergent Biosolutions Fundamental Analysis

We analyze Emergent Biosolutions' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emergent Biosolutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emergent Biosolutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Profit Margin

Profit Margin Comparative Analysis

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Peers

Trending Equities

ARMK  2.47   
0%
17.0%
XOM  1.84   
0%
12.0%
BNPQF  0.70   
0%
4.0%
VLUE  0.25   
0%
1.0%
VST  0.24   
0%
1.0%
POW  0.20   
0%
1.0%
QYLD  0.11   
0%
1.0%
FMURX  0.10   
0%
1.0%
MHNC  0.05   
0%
1.0%
TAXI  0.00   
0%
0%
HAR  0.00   
0%
0%
SSS  0.00   
0%
0%
HZNSF  0.00   
0%
0%
GDI  0.00   
0%
0%
DPS  0.00   
0%
0%
VGLT  0.39   
2.0%
0%
FRHC  1.62   
11.0%
0%
AMN  1.76   
12.0%
0%
MOTO  2.07   
14.0%
0%
TWST  14.20   
100.0%
0%
Continue to Investing Opportunities. Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Tools for Emergent Stock

When running Emergent Biosolutions price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go